Peter MacCallum Cancer Centre Highlights Its Experts’ Contributions at ESMO 2026 / Annette Lim, Annie Wong, Arun Azad, Ben ...
Promising Advances and Remaining Challenges / Acute Lymphoblastic Leukemia, Adult ALL, ALL, blinatumomab, cancer, Headlines, ...
The AACR John and Elizabeth Leonard Basic Cancer Research Fellowship 2027 provides $130,000 over two years to support ...
Excited About the NIH SOM Center, Building Validated Protocols and Open Access / Anthony Letai, cancer, National Cancer ...
Dario Trapani: Rethinking How We Measure Benefit in Cancer Care ...
Dario Trapani: Rethinking How We Measure Benefit in Cancer Care ...
Fabrice Andre: Key Reflections on Innovation, Transformation and Community From ESMO 2026 ...
All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or ...
At the ESMO Congress 2026, Ana Oaknin (Majadahonda, Spain) presented final overall survival (OS) results from the phase III BEATcc trial (NCT03556839), evaluating the addition of atezolizumab to first ...
SHR-A2102 at ESMO 2026 Shows 47.2% Response Rate in Recurrent or Metastatic Cervical Cancer / cancer, ESMO, esmo 2026, ...
At the Community Oncology Global Congress (COGC 2026), organized by OncoDaily, Amol Akhade, Senior Consultant in Medical ...
At the ESMO Congress 2026, Vanda Salutari (Rome, Italy) presented updated results from the phase I BEHOLD-1 trial (NCT06431594), evaluating mocertatug rezetecan (Mo-Rez), a B7-H4-targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results